ES2112244T3 - Compuestos de disulfuro del complejo ll-33288. - Google Patents

Compuestos de disulfuro del complejo ll-33288.

Info

Publication number
ES2112244T3
ES2112244T3 ES90106631T ES90106631T ES2112244T3 ES 2112244 T3 ES2112244 T3 ES 2112244T3 ES 90106631 T ES90106631 T ES 90106631T ES 90106631 T ES90106631 T ES 90106631T ES 2112244 T3 ES2112244 T3 ES 2112244T3
Authority
ES
Spain
Prior art keywords
complex
disulfide compounds
conjugates
analogs
carrier drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90106631T
Other languages
English (en)
Inventor
George A Ellestad
William James Mcgahren
Martin Leon Sassiver
Philip R Hamann
Lois M Hinman
Janis Upeslacis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/339,343 external-priority patent/US5053394A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2112244T3 publication Critical patent/ES2112244T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treating Waste Gases (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Lubricants (AREA)
  • Engine Equipment That Uses Special Cycles (AREA)

Abstract

SE DESCRIBEN ANALOGOS DISULFUROS DE AGENTES ANTITUMORALES Y ANTIBACTERICIANOS, CONOCIDOS COLECTIVAMENTE COMO COMPLEJO LL-E33288. ASI MISMO, SE DESCRIBE UN METODO PARA CONSTRUIR LOS CONJUGADOS DE LA DROGA PORTADORA, A PARTIR DE LOS ANALOGOS DISULFUROS, Y LOS CONJUGADOS DE LAS FORMAS EN ESTUDIO DE LA DROGA PORTADORA.
ES90106631T 1989-04-14 1990-04-06 Compuestos de disulfuro del complejo ll-33288. Expired - Lifetime ES2112244T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33932389A 1989-04-14 1989-04-14
US07/339,343 US5053394A (en) 1988-09-21 1989-04-14 Targeted forms of methyltrithio antitumor agents

Publications (1)

Publication Number Publication Date
ES2112244T3 true ES2112244T3 (es) 1998-04-01

Family

ID=26991573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90106631T Expired - Lifetime ES2112244T3 (es) 1989-04-14 1990-04-06 Compuestos de disulfuro del complejo ll-33288.

Country Status (16)

Country Link
EP (1) EP0392384B1 (es)
JP (1) JP2951684B2 (es)
CN (2) CN1046333A (es)
AT (1) ATE163293T1 (es)
AU (1) AU633069B2 (es)
CZ (1) CZ293228B6 (es)
DE (1) DE69032051T2 (es)
DK (1) DK0392384T3 (es)
ES (1) ES2112244T3 (es)
FI (1) FI100105B (es)
GR (1) GR3026177T3 (es)
IL (3) IL93733A (es)
NO (2) NO176717C (es)
NZ (1) NZ233148A (es)
PT (1) PT93716B (es)
SK (1) SK284270B6 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2
GB9120467D0 (en) * 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
US6015562A (en) * 1992-09-22 2000-01-18 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
JP6852065B2 (ja) 2015-10-20 2021-03-31 ジェネンテック， インコーポレイテッド カリケアマイシン−抗体−薬物コンジュゲート及び使用方法
JP6917049B2 (ja) * 2017-02-22 2021-08-11 公立大学法人大阪 特定のサルファイド化合物に結合する抗体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752355T2 (de) * 1987-01-30 2002-12-05 American Cyanamid Co., Wayne Dihydroderivate der Antibiotika vom Typ LL-E33288
EP0313874B1 (en) * 1987-10-30 1994-04-13 American Cyanamid Company Disulfur analogs of LL-E33288 antitumor agents

Also Published As

Publication number Publication date
EP0392384B1 (en) 1998-02-18
IL93733A0 (en) 1990-12-23
DE69032051T2 (de) 1998-06-10
NO901655L (no) 1990-10-15
EP0392384A3 (en) 1991-11-06
GR3026177T3 (en) 1998-05-29
IL115770A0 (en) 1996-01-19
JP2951684B2 (ja) 1999-09-20
JPH02292294A (ja) 1990-12-03
AU633069B2 (en) 1993-01-21
FI901866A0 (fi) 1990-04-12
FI100105B (fi) 1997-09-30
DK0392384T3 (da) 1998-03-16
CZ293228B6 (cs) 2004-03-17
DE69032051D1 (de) 1998-03-26
IL93733A (en) 1996-01-19
NO932192L (no) 1990-10-15
NO176717B (no) 1995-02-06
PT93716B (pt) 1996-08-30
CN1046333A (zh) 1990-10-24
NO176717C (no) 1995-05-16
SK188490A3 (en) 2000-08-16
NZ233148A (en) 1996-02-27
AU5324190A (en) 1990-11-01
NO177308B (no) 1995-05-15
IL115770A (en) 1999-03-12
CN1110280A (zh) 1995-10-18
ATE163293T1 (de) 1998-03-15
CZ188490A3 (cs) 2000-08-16
CN1109041C (zh) 2003-05-21
EP0392384A2 (en) 1990-10-17
NO177308C (no) 1995-08-23
SK284270B6 (sk) 2004-12-01
NO932192D0 (no) 1993-06-14
NO901655D0 (no) 1990-04-11
PT93716A (pt) 1990-11-20

Similar Documents

Publication Publication Date Title
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2052829T3 (es) Aminoetiltetralinas substituidas asi como sus analogos heterociclicos.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
ES2097448T3 (es) Sulfitos y sulfatos ciclicos de fructopiranosis con actividad anticonvulsiva.
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
ES2110230T3 (es) Ensayo de rapamicina.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
FI874064A7 (fi) Framstaellningsfoerfarande foer ytterdaeck, daer gummiartade produkter appliceras pao ett fast underlag, anordning med vilken ett dylikt foerfarande foerverkligas och maskin, daer dylika anordningar anvaends.
MX16158A (es) Un procedimiento para la preparacion de derivados aromaticos y heterociclicos de carboxiamida, utiles como agentes antitumorales
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
ES2147720T3 (es) Factor de celulas madre.
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
ES2071169T3 (es) 1-indolilalquil-4-(alcoxi-pirimidinil)piperazinas.
ES8503689A1 (es) "procedimiento para la obtencion de compuestos farmacologicamente activos por aislamiento de los factores individuales del complejo antibiotico teicomicina a2".
ES2060619T3 (es) Un procedimiento para la produccion de 3-hidrocarbil-3-cefems.
AR012155A1 (es) Mezclas solidas a base de sulfonilureas y adyuvantes, procedimiento para combatir el crecimiento de plantas con dichas mezclas y el procedimiento para prepararlas.
MX9702666A (es) Nuevos peptidos con efectos inmunoreguladores.
FR2431507A1 (fr) 1-desamino-2-desoxy-2-epi-amino fortimicine b
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
ES2079570T3 (es) Nuevas pirido(2,3-f)(1,4)tiazepinas y pirido(3,2-b)(1,5)benzotiazepinas.
ES2084101T3 (es) Fenoxialcanol como un estabilizante para isotiazolonas.
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
AR008781A1 (es) Compuestos de furano nitrona
FI874283A0 (fi) Isolerande produkt framstaelld pao platsen, fibrer och partiklar som ingaor i dess sammansaettning och framstaellningsfoerfarande.
SE8300486L (sv) Rengoringskomposition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 392384

Country of ref document: ES